Phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Saved in:
Bibliographic Details
Title: Phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Authors: Morath C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.; TolerogenixX GmbH, Heidelberg, Germany., Schmitt A; TolerogenixX GmbH, Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology., Kleist C; Transplantation Immunology, Institute of Immunology.; Department of Nuclear Medicine., Daniel V; Transplantation Immunology, Institute of Immunology., Opelz G; Transplantation Immunology, Institute of Immunology., Süsal C; Transplantation Immunology, Institute of Immunology., Ibrahim E; Transplantation Immunology, Institute of Immunology., Kälble F; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Speer C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Nusshag C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Pego da Silva L; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.; TolerogenixX GmbH, Heidelberg, Germany., Sommerer C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Wang L; TolerogenixX GmbH, Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology., Ni M; Department of Hematology, Oncology and Rheumatology., Hückelhoven-Krauss A; Department of Hematology, Oncology and Rheumatology., Czock D; Department of Clinical Pharmacology and Pharmacoepidemiology., Merle U; Department of Gastroenterology., Mehrabi A; Department of General, Visceral and Transplantation Surgery., Sander A; Institute of Medical Biometry and Informatics., Hackbusch M; Institute of Medical Biometry and Informatics., Eckert C; Institute of Pathology, and., Waldherr R; Institute of Pathology, and., Schnitzler P; Virology, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Hematology, Oncology and Rheumatology., Hoheisel JD; Division of Functional Genome Analysis, DKFZ, Heidelberg, Germany., Mustafa SA; Division of Functional Genome Analysis, DKFZ, Heidelberg, Germany.; Kurdistan Institution for Strategic Studies and Scientific Research, Kurdistan Region, Iraq., Alhamdani MS; Division of Functional Genome Analysis, DKFZ, Heidelberg, Germany., Bauer AS; Division of Functional Genome Analysis, DKFZ, Heidelberg, Germany., Reiser J; Department of Medicine, Rush Medical College, Rush University, Chicago, Illinois, USA., Zeier M; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany., Schmitt M; Department of Hematology, Oncology and Rheumatology., Schaier M; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.; TolerogenixX GmbH, Heidelberg, Germany., Terness P; Transplantation Immunology, Institute of Immunology.
Source: The Journal of clinical investigation [J Clin Invest] 2020 May 01; Vol. 130 (5), pp. 2364-2376.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI133595